Risk factors for intra-abdominal infection after pancreas transplantation

被引:29
作者
Knight, RJ
Bodian, C
Rodriguez-Laiz, G
Guy, SR
Fishbein, TM
机构
[1] Mt Sinai Med Ctr, Dept Surg, Recanati Miller Transplantat Inst, New York, NY 10029 USA
[2] Mt Sinai Med Ctr, Dept Biomath Sci, New York, NY 10029 USA
[3] Temple Univ, Sch Med, Dept Surg, Philadelphia, PA 19122 USA
关键词
D O I
10.1016/S0002-9610(00)00276-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: This study was designed to determine risk factors for intra-abdominal abscess after pancreas transplantation. METHODS: We performed a single-center retrospective review of all pancreas transplants from 1994 to 1999, Risk factors studied were donor age, body weight, body mass index, peak serum glucose, peak serum amylase, need for presser agents, cause of death, cold ischemic preservation time, recipient age, type of dialysis, surgical technique, and peak recipient amylase. RESULTS: The 1-year graft survival rate was 90%, Of the 34 patients studied, there were 4 cases of peripancreatic abscess formation (12%). Elevated donor body weight (P <0.01), elevated body mass index (P <0.05), and the peak recipient serum amylase in the first postoperative week (P <0.01) were significant risk factors for the development of intra-abdominal infection. CONCLUSIONS: These data suggest that pancreas grafts from obese donors may be more susceptible to ischemia-reperfusion injury resulting in abscess formation, Am J Surg. 2000;179:99-102. (C) 2000 by Excerpta Medica, Inc.
引用
收藏
页码:99 / 102
页数:4
相关论文
共 11 条
[1]   A prospective randomized clinical trial of perioperative treatment with octreotide in pancreas transplantation [J].
Benedetti, E ;
Coady, NT ;
Asolati, M ;
Stormoen, BM ;
Bartholomew, AM ;
Vasquez, EM ;
Pollak, R .
AMERICAN JOURNAL OF SURGERY, 1998, 175 (01) :14-17
[2]  
Esterl RM, 1995, TRANSPLANT P, V27, P3057
[3]  
EVERETT JE, 1994, ARCH SURG-CHICAGO, V129, P1310
[4]  
GRUESSNER A, 1997, CLIN TRANSPLANTS 199, P47
[5]   Donor and recipient risk factors significantly affect cost of pancreas transplants [J].
Gruessner, AC ;
Troppmann, C ;
Sutherland, DER ;
Gruessner, RWG .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :656-657
[6]   The surgical risk of pancreas transplantation in the cyclosporine era: An overview [J].
Gruessner, RWG ;
Sutherland, DER ;
Troppmann, C ;
Benedetti, E ;
Hakim, N ;
Dunn, DL ;
Gruessner, AC .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1997, 185 (02) :128-144
[7]   Strategies to expand the donor pool for pancreas transplantation [J].
Kapur, S ;
Bonham, CA ;
Dodson, SF ;
Dvorchik, I ;
Corry, RJ .
TRANSPLANTATION, 1999, 67 (02) :284-290
[8]  
Papalois BE, 1996, ARCH SURG-CHICAGO, V131, P761
[9]   Experience with 500 simultaneous pancreas-kidney transplants [J].
Sollinger, HW ;
Odorico, JS ;
Knechtle, SJ ;
D'Alessandro, AM ;
Kalayoglu, M ;
Pirsch, JD .
ANNALS OF SURGERY, 1998, 228 (03) :284-294
[10]  
STRATTA RJ, 1999, 7 WORLD C INT PANCR